A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants (Q45125924)

9 December 2017

title

A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants (English)

1 reference

9 December 2017

0 references

Sirvent-Von Bueltzingsloewen A

1

1 reference

9 December 2017

Morand P

2

1 reference

9 December 2017

Buisson M

3

1 reference

9 December 2017

Souillet G

4

1 reference

9 December 2017

Chambost H

5

1 reference

9 December 2017

Bosson JL

6

1 reference

9 December 2017

Bordigoni P

7

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Bone Marrow Transplantation

9 December 2017

published in

1 reference

9 December 2017

volume

29

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

21-28

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703331

9 December 2017

exact match

0 references

cites work

Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Detection of Epstein-Barr virus DNA in serum of transplanted patients: a new diagnostic guide for lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr virus exclusively in the immunoglobulin D-negative B-cell compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703331

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703331

1 reference

Dimensions Publication ID

9 December 2017

1044618189

0 references

1 reference